Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001689375-25-000016

Chief Financial Officer sold 1,784 shares at $10.67 ($19,035)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
WENTWORTH KORY JAMES Chief Financial Officer 2025-03-17 Sale 10b5-1 −1,784 $10.67 $19,035 109,536 D: show line 1 in the form
Open-market sales · 1,784 sh · avg $10.67 · $19,035
Loading xslF345X05/wk-form4_1742416340.xml…